Carboprost Versus Oxytocin for Active Management of Third Stage of Labor: A Prospective Randomized Control Study
Authors:
- 22 March 2016
- journal article
- research article
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 66 (S1) , 229-234
Abstract
Background and Objectives Postpartum hemorrhage is the single largest and leading cause of maternal morbidity and mortality not only in developing countries but also in developed countries. The present study is an attempt to evaluate the scope of using prophylactic intramuscular carboprost tromethamine 125 μg in comparison with intramuscular oxytocin 10 units for the active management of third stage of labor. Materials and Methods Two hundred pregnant women at term with spontaneous onset of labor were included in the study and were randomly divided into 2 groups of 100 women each. Group A and group B were given injection oxytocin 10 units and injection carboprost tromethamine 125 μg intramuscularly, respectively, at the time of delivery of anterior shoulder. The main outcome measures with respect to third stage of labor were: duration, blood loss by volume, difference in hemoglobin, need for additional oxytocics and side effects. Results Subjects who received carboprost tromethamine 125 μg showed a significant reduction in duration of third stage of labor (p < 0.05) and blood loss (p < 0.01) when compared to the subjects who received oxytocin 10 units. Likelihood of occurrence of postpartum hemorrhage was reduced without significant side effects except for diarrhea. Additional need for other uterotonics after carboprost was significantly less compared to oxytocin. Conclusion Intramuscular carboprost 125 μg is a better cost-effective alternative as compared to 10 units intramuscular oxytocin in active management of third stage of labor.Keywords
This publication has 13 references indexed in Scilit:
- A comparison of oxytocin and carboprost tromethamine in the prevention of postpartum hemorrhage in high-risk patients undergoing cesarean deliveryExperimental and Therapeutic Medicine, 2013
- Which Uterotonic Is Better to Prevent the Postpartum Hemorrhage? Latest News in Terms of Clinical Efficacy, Side Effects, and Contraindications: A Systematic ReviewReproductive Sciences, 2013
- Dose and Duration of Oxytocin to Prevent Postpartum Hemorrhage: A ReviewAmerican Journal of Perinatology, 2012
- Active versus expectant management for women in the third stage of labour2011
- Active Management of the Third Stage of Labour: Prevention and Treatment of Postpartum HemorrhageJournal of Obstetrics and Gynaecology Canada, 2009
- A randomized controlled trial of prophylactic sublingual misoprostol versus intramuscular methyl-ergometrine versus intramuscular 15-methyl PGF2α in active management of third stage of laborArchives of Gynecology and Obstetrics, 2009
- Epidemiology of postpartum haemorrhage: a systematic reviewBest Practice & Research Clinical Obstetrics & Gynaecology, 2008
- Prevention and Treatment Of Post‐partum HaemorrhageInternational Journal of Gynecology & Obstetrics, 2007
- Carboprost trometamol in the management of the third stage of laborInternational Journal of Gynecology & Obstetrics, 1993
- The Use of 15 Methyl F2αProstaglandin (Prostin 15M) for the Control of Postpartum HemorrhageAmerican Journal of Perinatology, 1986